Market Tracker

03/27 6:01pm ET

Rosetta Genomics Ltd (NASDAQ:ROSG)

2.98
Delayed Data
As of Mar 27
 -0.075 / -2.46%
Today’s Change
2.07
Today|||52-Week Range
5.55
+31.64%
Year-to-Date
No recent news for Rosetta Genomics Ltd.

Today’s Trading

Previous close3.05
Today’s open3.06
Day’s range2.93 - 3.08
Volume94,121
Average volume (3 months)670,804
Market cap$35.0M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+3.73%
Earnings growth (this year)-179.75%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+227.65%
P/E ratio--
Price/Sales19.14
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
KDUSCadus Corp+0.05+3.85%
ENZBEnzymeBioSystems+0.01+1.11%
OXGNOXiGENE Inc+0.03+2.16%
SNGXSoligenix Inc-0.01-0.60%
Data as of 4:00pm ET, 03/27/2015

Financials

Last reporting dateNovember 7, 2013
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$1.3M
Annual profit (last year)-$14.5M
Net profit margin-1,094.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Head-Investor Relations
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, --

Forecasts